Traumatic Hemothorax Drainage and Daily Lavage
Sponsor: University of Pennsylvania • ClinicalTrials.gov ID: NCT06937450
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
This HTX treatment study evaluates the effects of chest tube size and the benefits of daily irrigations on acute HTX. 20 acutely injured but stable trauma patients requiring a chest tube for HTX will be enrolled. Patients will be assigned a 28Fr or 14 Fr chest tube with serial lavage and drainage. The endpoints will be HTX volume (by CT scan), complications, additional interventions, hospital length of stay, chest tube duration, provider feedback, and patient-reported outcomes.
Interventions
-
CLR Irrigator
(Device)
All enrolled patients will have their hemothorax treated with a CLR device that allows for easy suction and irrigation through indwelling catheters,
-
Serial Lavage and Drainage
(Procedure)
The current protocol is to do a singular lavage and drainage, this study will investigate the benefits of daily lavage.
-
28 Fr Open Chest Tube
(Device)
Patients will have a standard 28 Fr open chest tube or a percutaneous 14Fr chest tube placed.
-
Percutaneous 14Fr Chest Tube
(Device)
Patients will have a standard 28 Fr open chest tube, or a percutaneous 14Fr chest tube placed.
Eligibility criteria
Conditions
Locations
- Penn Presbyterian Medical Center — Philadelphia, Pennsylvania, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record